Work

Abstract C030: HARMONi-3: A randomized, controlled, multiregional Phase 3 study of ivonescimab combined with chemotherapy versus pembrolizumab combined with chemotherapy for the first-line treatment of metastatic squamous non-small cell lung cancer

Year: 2023

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-23-c030

Authors: Jonathan Riess, Shun Lu, Jarushka Naidoo, Sara Kuruvilla, Annie Hung, Ahmed Khaled, Deborah Doroshow

Institutions: UC Davis Comprehensive Cancer Center, University of California, Davis, Shanghai Jiao Tong University, Shanghai Chest Hospital, Royal College of Surgeons in Ireland, Beaumont Hospital, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389242346

Cites:

Cited by: 2

Related to: 10